These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 6622509

  • 1. Effects of acarbose on food intake, body weight and fat depots in lean and obese rats.
    Glick Z, Bray GA.
    Pharmacol Biochem Behav; 1983 Jul; 19(1):71-8. PubMed ID: 6622509
    [No Abstract] [Full Text] [Related]

  • 2. Effects of a glucosidase inhibitor (acarbose, BAY g 5421) on the development of obesity and food motivated behavior in Zucker (fafa) rats.
    Vasselli JR, Haraczkiewicz E, Maggio CA, Greenwood MR.
    Pharmacol Biochem Behav; 1983 Jul; 19(1):85-95. PubMed ID: 6622510
    [Abstract] [Full Text] [Related]

  • 3. Effect of acarbose (BAY-g-5421) on expression of noninsulin-dependent diabetes mellitus in sucrose-fed SHR/N-corpulent rats.
    Carswell N, Michaelis OE, Prather ES.
    J Nutr; 1989 Mar; 119(3):388-94. PubMed ID: 2646401
    [Abstract] [Full Text] [Related]

  • 4. The effect of acarbose on the food intake, weight gain, and adiposity of LA/N-cp rats.
    Vedula U, Schnitzer-Polokoff R, Tulp OL.
    Comp Biochem Physiol A Comp Physiol; 1991 Mar; 100(2):477-82. PubMed ID: 1685964
    [Abstract] [Full Text] [Related]

  • 5. Influence of acarbose on hyperglycemia induced by various carbohydrates in rats and oral starch tolerance in monkeys.
    Ho RS, Aranda CG.
    Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):147-56. PubMed ID: 6847313
    [Abstract] [Full Text] [Related]

  • 6. Effect of acarbose on exocrine and endocrine pancreatic function in the rat.
    Otsuki M, Sakamoto C, Ohki A, Okabayashi Y, Suehiro I, Baba S.
    Diabetologia; 1983 Jun; 24(6):445-8. PubMed ID: 6193016
    [Abstract] [Full Text] [Related]

  • 7. Effect of phenoxybenzamine on development of adipose tissue in lean and obese Zucker rats.
    Comai K, Sullivan AC.
    Am J Physiol; 1982 Nov; 243(5):E398-406. PubMed ID: 7137343
    [Abstract] [Full Text] [Related]

  • 8. Metabolic effects of acarbose administration in normal and diabetic rats.
    Haugaard N, Hess ME, Locke CL, Torbati A, Wildey G.
    Biochem Pharmacol; 1984 May 01; 33(9):1503-8. PubMed ID: 6732866
    [Abstract] [Full Text] [Related]

  • 9. Positive effects of acarbose in the diabetic rat are not altered by feeding schedule.
    Wright BE, Vasselli JR, Katovich MJ.
    Physiol Behav; 1998 Mar 01; 63(5):867-74. PubMed ID: 9618010
    [Abstract] [Full Text] [Related]

  • 10. Modification of weight gain by an alpha-glucosidase inhibitor during refeeding in rats.
    Kotler DP, Tierney AR, Kral JG, Bjorntorp P.
    Am J Clin Nutr; 1984 Aug 01; 40(2):270-6. PubMed ID: 6380264
    [Abstract] [Full Text] [Related]

  • 11. alpha-Glucosidase inhibition in obesity.
    William-Olsson T.
    Acta Med Scand Suppl; 1985 Aug 01; 706():1-39. PubMed ID: 3914827
    [Abstract] [Full Text] [Related]

  • 12. Serotonin delivery into the ventromedial nucleus of the hypothalamus affects differently feeding pattern and body weight in obese and lean Zucker rats.
    Fetissov SO, Meguid MM.
    Appetite; 2010 Apr 01; 54(2):346-53. PubMed ID: 20060864
    [Abstract] [Full Text] [Related]

  • 13. Insulin binding and glucose transport in adipocytes of acarbose-treated Zucker lean and obese rats.
    Vasselli JR, Flory T, Fried SK.
    Int J Obes; 1987 Apr 01; 11 Suppl 3():71-5. PubMed ID: 3326849
    [Abstract] [Full Text] [Related]

  • 14. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.
    de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF.
    Diabetes; 2001 Aug 01; 50(8):1863-71. PubMed ID: 11473050
    [Abstract] [Full Text] [Related]

  • 15. [Preliminary experiments on the effects of glucosidase inhibitor in fattening pigs].
    Bronsch K, Schneider D, Kühl K, Andrzejak N.
    Z Tierphysiol Tierernahr Futtermittelkd; 1980 Aug 01; 44(1):36-46. PubMed ID: 7424206
    [No Abstract] [Full Text] [Related]

  • 16. Effect of adrenalectomy and glucocorticoid replacement on development of obesity.
    Freedman MR, Horwitz BA, Stern JS.
    Am J Physiol; 1986 Apr 01; 250(4 Pt 2):R595-607. PubMed ID: 3515971
    [Abstract] [Full Text] [Related]

  • 17. The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones.
    Bing C, King P, Pickavance L, Brown M, Ziegler D, Kaan E, Williams G.
    Br J Pharmacol; 1999 May 01; 127(1):35-42. PubMed ID: 10369453
    [Abstract] [Full Text] [Related]

  • 18. Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats.
    Michel O, Heudes D, Lamarre I, Masurier C, Lavau M, Bariety J, Chevalier J.
    Kidney Int; 1997 Dec 01; 52(6):1532-42. PubMed ID: 9407498
    [Abstract] [Full Text] [Related]

  • 19. In vitro inhibition of rat pancreatic amylase by acarbose.
    Mukherjee B, Chatterjee AK, Mukherjee SK.
    Indian J Biochem Biophys; 1982 Aug 01; 19(4):288-9. PubMed ID: 6187666
    [No Abstract] [Full Text] [Related]

  • 20. Metabolic effects of acarbose in normal and diabetic rats: long- and short-term administration.
    Hess ME, Haugaard N, Min W, Torbati A.
    Arch Int Pharmacodyn Ther; 1986 Sep 01; 283(1):163-76. PubMed ID: 3800510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.